1-1 of 1
Frederick Locke, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation (Hct) in Patients with Advanced Hematologic Malignancies: A Phase I–II Study

Koen Van Besien, Frederick Locke, MD, Justin Kline, Lucy Godley, MD, PhD, Richard A. Larson, MD, Olatoyosi Odenike, MD, Elizabeth Shima Rich, MD, PhD, Wendy Stock, MD, Amittha Wickrema, PhD, Andrew Artz, MD, MS
Journal: Blood
Blood (2008) 112 (11): 4381.
https://doi.org/10.1182/blood.V112.11.4381.4381
Published: 2008